Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00606151 · ClinicalTrials.gov registry record
PeriOperative Bridging - Perioperative Anticoagulation in the Setting of Recent Intracoronary Drug Eluting Stents
A clinical trial, sponsored by The Cleveland Clinic.
- Terminated
- Registry status
- 60
- Enrollment target
NCT00606151 is a clinical trial that was terminated before completion, run by The Cleveland Clinic. The registered enrollment target is 60 participants.
The verdict
NCT00606151 was terminated before completion, sponsored by The Cleveland Clinic.
- TERMINATED
- Registry status
- 60 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if an intravenous (IV) antiplatelet medication is as safe and effective at preventing clot formation in your stented artery as compared in people who have stopped clopidogrel prior to surgery.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2008-01 |
| Est. Completion | 2009-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00606151
The ClinicalTrials.gov registry entry for NCT00606151 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00606151 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00606151 about?
NCT00606151 is a clinical study titled "PeriOperative Bridging - Perioperative Anticoagulation in the Setting of Recent Intracoronary Drug Eluting Stents". The purpose of this study is to determine if an intravenous (IV) antiplatelet medication is as safe and effective at preventing clot formation in your stented artery as compared in people who have stopped clopidogrel prior to surgery.
What is the current status of trial NCT00606151?
This trial is currently terminated. The enrollment target is 60 participants. The study started on 2008-01. Estimated completion is 2009-01.
Who is sponsoring clinical trial NCT00606151?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.